next-generation alk inhibitors: treatment sequencing and resistance
Published 2 years ago • 275 plays • Length 1:42Download video MP4
Download video MP3
Similar videos
-
3:34
alk-positive nsclc: the role of treatment selection and sequencing
-
2:10
molecularly-guided treatment of advanced nsclc: alk inhibitor sequencing
-
6:27
alk inhibitor sequencing in nsclc
-
5:09
alk mutations in ctdna predict responses to next generation alk tkis in nsclc
-
2:07
clinical updates on alk inhibitor treatment strategies for nsclc
-
1:24
choosing the best alk inhibitor for lung cancer
-
22:10
first and second generation alk inhibitors for the treatment of lung cancer
-
8:35
next generation alk inhibitors for nsclc
-
6:41
next-generation alk inhibitors for nsclc
-
6:36
sequencing strategies for alk-targeted therapy
-
2:00
updated data from phase 2 study of alectinib in alk–positive non–small–cell lung cancer
-
3:44
alk inhibitors for acquired resistance: zykadia and alectinib
-
4:23
efficacy of next-generation alk inhibitors in nsclc
-
1:01
targeting alk rearrangements in non-small cell lung cancer
-
1:25
updates and unmet needs in alk-mutated lung cancer
-
5:18
utilizing next-generation alk inhibitors in nsclc
-
0:56
nautika1: safety and tolerability of neoadjuvant alectinib in alk-positive nsclc
-
6:27
next generation inhibitors help overcome problems of resistance in alk positive lung cancer
-
8:17
third-generation alk inhibitors for nsclc